Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY12.29 CNY
Change Today -0.25 / -1.99%
Volume 4.0M
002688 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

jinhe biotechnology co ltd-a (002688) Snapshot

Open
CNY12.00
Previous Close
CNY12.54
Day High
CNY13.04
Day Low
CNY11.88
52 Week High
06/1/15 - CNY29.70
52 Week Low
09/2/15 - CNY11.88
Market Cap
2.7B
Average Volume 10 Days
6.8M
EPS TTM
CNY0.44
Shares Outstanding
217.8M
EX-Date
05/22/15
P/E TM
27.7x
Dividend
CNY0.10
Dividend Yield
0.81%
Current Stock Chart for JINHE BIOTECHNOLOGY CO LTD-A (002688)

Related News

No related news articles were found.

jinhe biotechnology co ltd-a (002688) Related Businessweek News

No Related Businessweek News Found

jinhe biotechnology co ltd-a (002688) Details

Jinhe Biotechnology Co., Ltd. is engaged in the production and sale of veterinary medicines in the China. It offers chlortetracycline feed grade, an antimicrobial drug for the inhibition and treatment of white dysentery, enteritis, pheumonia, typhoid, paratyphoid, and cholera in poultry and livestock; chlortetracycline hydrochloride for the inhibition and treatment of pullorum disease, typhoid, swine enteritis, and bacterial diseases, such as paratyphoid and cholera; and salinomycin used for the treatment of eimeria of chickens, including e.necatrix, tenella, maxima, hehuan, acervulin, and brinell, as well as in the inhibition of gram-positive bacteria. The company exports its products to the United States, southeast Asia, Latin America, and Europe. Jinhe Biotechnology Co., Ltd. is based in Dalian, China.

jinhe biotechnology co ltd-a (002688) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jinhe biotechnology co ltd-a (002688) Key Developments

Jinhe Biotechnology Co., Ltd. to Report First Half, 2015 Results on Aug 28, 2015

Jinhe Biotechnology Co., Ltd. announced that they will report first half, 2015 results on Aug 28, 2015

Jinhe Biotechnology Co., Ltd. Approves Amendments to the Articles of Association

Jinhe Biotechnology Co., Ltd. approved amendments to the articles of association of the company at its extraordinary general meeting of 2015 held on August 5, 2015.

Jinhe Biotechnology Co., Ltd. Proposes Amendments to its Articles of Association

Jinhe Biotechnology Co., Ltd. at the extraordinary general meeting of 2015 to be held on August 5, 2015, proposed amendments to the articles of association of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002688:CH CNY12.29 CNY -0.25

002688 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002688.
View Industry Companies
 

Industry Analysis

002688

Industry Average

Valuation 002688 Industry Range
Price/Earnings 34.1x
Price/Sales 2.7x
Price/Book 2.8x
Price/Cash Flow 33.1x
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JINHE BIOTECHNOLOGY CO LTD-A, please visit www.jinhe.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.